SMEs and the EMA: Promoting innovation and the development of new medicines 

2025 will mark the 20th anniversary of the Small and Medium Enterprise (SME) regulation, and the European Medicines Agency (EMA) continues to recognise SMEs as important actors in innovation and the development of new medicinal products. Incentives are provided to help SMEs overcome some of the financial and administrative hurdles associated with bringing a product to market.

Workshop Insights: Breaking the Chain of Sedentary Work

Recognizing the importance of a healthy and efficient work-from-home setup, we took a step by hosting a workshop on ergonomics, led by a IDEWE specialist. This session was aimed at helping our employees optimize their home offices to prevent discomfort and injury, focusing on practical adjustments like proper seating, desk setup, and the positioning of computer equipment.

RIP Responsibilities

𝐃𝐨 𝐲𝐨𝐮 𝐤𝐧𝐨𝐰 𝐰𝐡𝐚𝐭 𝐑𝐈𝐏 𝐫𝐞𝐚𝐥𝐥𝐲 𝐦𝐞𝐚𝐧𝐬?!

PHAROS blog post

More price negotiations on new expensive drugs in the Netherlands

Evaluation of digital medical technologies in Belgium

Recently, the Belgian Healthcare Knowledge Center (KCE) published a report on the evaluation of digital medical technologies, to which Sven and Frank participated as stakeholders and Domien contributed as an external validator.

Regulatory Compliance

Many people working in Pharmaceutical or Medtech companies ask us what kind of a consulting agency AxTalis is nowadays. Therefore, we are keen to inform you what you can expect working with us.

Welcome to our team!

We are honoured to be joined by Sabrina Lagniau as Regulatory Affairs Officer.

Merry Christmas!

Dear network,

The AxTalis team wishes you a joyous Christmas and a happy, fulfilling, new year!